Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Business

Bio Spectrum

Bio Spectrum

Ensuring Biotech Startup Success Stories

According to the Indian BioEconomy Report 2025, the number of biotech startups has more than doubled from 4237 in 2020 to 10,075 in 2024.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Unlocking Future of Large and Small Molecule Pharma R&D with Science-Driven Digital Solutions

As pharmaceutical companies expand their R&D operations globally, Indian Contract Development and Manufacturing Organisations (CDMOs) are attracting significant investment.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Medical Device Classification and FDA Approva:What Startups Need to Know

For many innovators, the United States represents a key market, being the world’s largest for medical devices.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

BiomatiQ Inaugurates State-of-the-Art, Fully Automated Production Line for Ready-to-Use Culture Media

Hyderabad, India - BiomatiQ, a leading life science products distribution company, has marked a significant milestone with the inauguration of its state-of-the-art, fully automated production line for ready-to-use culture media.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Can technology uplift the Indian BioSuppliers ecosystem?

The bioindustrial and biopharma segment have emerged as the two key sectors contributing majorly (82 per cent) to India's bioeconomy which stands at $165.7 billion in 2024.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

"Evolving regulatory requirements, heightened scrutiny from regulatory agencies, and geopolitical uncertainties pose challenges"

Strides Pharma Science demerged its Contract Development and Manufacturing Organisation (CDMO) business into OneSource Specialty Pharma Ltd, following approval by the National Company Law Tribunal (NCLT) in 2024.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

"The biosimilar developers are eagerly awaiting revised CDSCO regulations that might lead to simplification of the development pathway for biosimilars"

How has India's biosimilars landscape evolved over the past 25 years, and what have been the most significant milestones?

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

"Govt initiatives and private sector investments are boosting adoption of NGS technologies for various applications"

Illumina, a global leader in DNA sequencing and array-based technologies, recently launched the MiSeq i100 and MiSeq i100 Plus Systems.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Specialised Skill Development for GCCs in India

India is a key hub for Life Sciences and Healthcare (LSHC) Global Capability Centers (GCCs).

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Health Ministry releases national guidelines on medical oxygen management

The Ministry of Health and Family Welfare, Government of India, has released the National Guidelines on Medical Oxygen Management at a workshop held at the All India Institute of Medical Sciences (AIIMS), Delhi.

1 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Biomarkers in Kidney Health: Enhancing Early Detection and Treatments

Emerging biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have shown great potential in the early diagnosis of kidney injury.

4 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Mushrooming Generics.Turn Affordable Lifeline

The Indian pharmaceutical market is witnessing a dramatic transformation following the patent expiry of Empagliflozin (sold under the brand name Jardiance by Boehringer Ingelheim) on March 11, 2025, used for treatment of adults with type 2 diabetes mellitus, as an adjunct to diet and exercise to improve glycemic control and to reduce the risk of cardiovascular death in patients with established cardiovascular disease.

2 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Nagaland University announces undergraduate programme in Basic Sciences

Nagaland University is launching anew undergraduate programme in Basic Sciences from the Academic Year 2025-26.

1 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

25 Transformative Years of BIOSIMILARS

BIOSIMILARS

6 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

India's Biosimilars Revolution

The increasing incidence of chronic illnesses such as cancer, diabetes, and autoimmune disorders, which necessitate long-term biologic therapies, is driving the growth of the biosimilar market in India.

5 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Ankura Hospitals secures Rs 165 Cr funding from ADB

Hyderabad-based Ankura Hospitals, a leading healthcare provider specialising in super-specialty tertiary and quaternary care services for women and children, has secured Rs 165 crore in funding from the Asian Development Bank (ADB).

1 min  |

BioSpectrum India May 2025
Bio Spectrum

Bio Spectrum

Alvarez & Marsal strengthens healthcare & life sciences practice with appointment of Akash Kedia as MD

Leading global professional services firm Alvarez & Marsal (A&M) India has announced the appointment of Akash Kedia as Managing Director (MD) within its Life Sciences Business Transformation Services practice.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Salubrious Technologies launches new digital platform to connect doctors with patients

India’s healthcare system is at a crossroads, with digital transformation accelerating, yet critical gaps in accessibility and efficiency still persisting.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

CrisprBits develops PathCrisp for early detection of antibiotic resistance

Bengaluru-based biotechnology startup CrisprBits has developed PathCrisp, a platform for CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Practo ropes in Jagnoor Singh as COO to drive strategic growth

Practo has announced the appointment of Jagnoor Singh as the Chief Operating Officer (COO). This appointment supports Practo's vision of improving health outcomes while building a profitable, innovative, and user-focused business.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Genefitletics unveils Agegorithm to measure biological age

Delhi-based startup Genefitletics has launched Agegorithm, a machine learning driven human biology model that quantifies biology at molecular & cellular level to measure biological age.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

ICMR publishes addendum to ethical requirements for research in integrative medicine

The Indian Council of Medical Research (ICMR) has published an addendum to the ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2017) to provide a structured ethical framework for Research in Integrative Medicine (RIM).

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

"Only the anonymised summary of clinical variants in the BCGA is accessible to clinicians"

IT-Madras embarked on an initiative to build India's Cancer Genome Database, which can completely transform cancer research in India.

2 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Wipro GE Healthcare launches AI enabled ultrasound system Versana Premier R3

Wipro GE Healthcare has announced the launch of the Versana Premier R3, an advanced artificial intelligence (AI)-enabled ultrasound system designed to enhance clinical efficiency and accuracy, streamline workflows, and improve patient outcomes.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

RIPPLE EFFECT of Cancer Drug Duty Cuts

To ease the financial strain on patients, the Union Budget 2025-26 has removed Basic Customs Duty (BCD) on 36 life-saving drugs used for cancer, rare diseases, and chronic conditions. This move is expected to make essential treatments more affordable by lowering overall costs. However, the real question remains: will this truly reduce the financial burden on patients? As prices decrease, what effects will this have on pharmaceutical companies, particularly in terms of sales and competition? Most importantly, how will local players adapt to these changes? Let's find out.

8 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Eris Lifesciences appoints Murari Ranganathan to spearhead Cardiometabolic Business

Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company has appointed Murari Ranganathan as President, of Cardiometabolic Business.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy's Laboratories

Ahmedabad-based Senores Pharmaceuticals Limited (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (SPI), has signed agreements to acquire a basket of 14 Abbreviated New Drug Applications (ANDAs) from Hyderabad-based Dr. Reddy’s Laboratories and its applicable affiliates.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Parse Biosciences plans to release single cell chromatin accessibility products

The US-based Parse Biosciences, the leader in accessible and scalable single cell sequencing, has affirmed plans to proceed with the development and future release of their Evercode single-cell chromatin products.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Motilal Oswal Alternates invests Rs 460 Cr in Megafine Pharma

Motilal Oswal Alternate Investment Advisors Private Limited (MO Alts) has agreed to invest upto Rs 460 crore for a majority stake in Mega Fine Pharma Private Limited.

1 min  |

BioSpectrum India April 2025
Bio Spectrum

Bio Spectrum

Scientists at IISc tweak cancer cell response to ultrasound treatment

Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular matrix (ECM) surrounding the cells, allowing them to grow and spread.

1 min  |

BioSpectrum India April 2025